The general public as a whole are lost when it comes to the complete understanding of how a clinical trial can benefit their potential treatment plans. There is enough information on the web by all means, but how do you get the information to an individual and explain both the potential benefits...
Posted to
The Medical Quack .... by Barbara Duck
on 11-07-2008
Filed under: Medically Related, Technology, drugs, healthcare, EHR, Pharma, PHR, clinical trials, Software integration, Point of Care, Personalized Clinical Trials
Investors and analysts using The Healthcare Exchange will be able to ask questions of physicians, such as their opinions about a new treatment or device. Sermo has been a community website restricted to physicians to compare and collaborate within their peers and now with the new service investors...
Posted to
The Medical Quack .... by Barbara Duck
on 10-23-2008
Filed under: Medically Related, Technology, Other Items of Interest, drugs, healthcare, Investors, Physicians, Prescriptions, clinical trials, Sermo, Bloomberg, MCconnect, opinions
Other Pharma businesses have done or will be doing the same, much of R and D is moving other areas where the cost is 1/5 of that here in the US, so 5 times the number of projects ongoing for the same amount of money, which also means in the same terms there can be 4 failures of drugs in the same cost...
This is probably a good move to speed this process up since many pharmaceutical companies have and are looking at moving more trials to India. More information can be read here about the changing face of Pharma in reference to research and development. One more area to think about too is the use...
Posted to
The Medical Quack .... by Barbara Duck
on 09-19-2008
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Cancer, clinical trials, Congress, DNA Testing, National Cancer Institute, Justice Department
With all the focus on cancer of late, which is of course very important, it's nice to see some other research and good clinical results for other chronic conditions, such as Gout. I have watch my mother, who is 84 years old, and who is also a diabetic who has gout, for years, trying to balance...
This is one tough subject by all means. Yes, consumers want early access, but on the other hand if there’s not enough information regarding issues such as side effects, a drug could in fact hasten the process with individuals dying sooner, again studies are what is needed to be safe. ...
Posted to
The Medical Quack .... by Barbara Duck
on 07-07-2008
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, Cancer, FDA, clinical trials, Research, University of California